Lack of Coherent Testing Strategy Creates Uncertainties for Clinical Laboratories about COVID-19 Testing Volumes
![national-testing-strategy-SARS-CoV-2-coalition](https://covid19briefings.com/wp-content/uploads/2020/06/AS_330654419-national-strategy-1024x719.jpg)
Influential quotes by Gary Procop, MD, MS, of the Cleveland Clinic, on the role of clinical laboratory and anatomic pathology group leaders in developing a national COVID-19 testing strategy.
Clinical Laboratories May Lose SARS-CoV-2 Testing Volumes to Veterinarian Labs
![vet-vs-human-testing-covid19](https://covid19briefings.com/wp-content/uploads/2020/06/AS_55861601-vet-vs-human-testing.jpeg)
Implications of blurring the lines between human testing laboratories and veterinarian labs.
HHS Announces New Guidance for SARS-CoV-2 Testing Reporting by Clinical Laboratories
![Requirements around COVID-19 testing](https://covid19briefings.com/wp-content/uploads/2020/06/AS_223206925-flat-requirements-federal.jpg)
SARS-CoV-2 test reporting requirements just multiplied. Clinical laboratories are on a deadline now.
FDA Issues List of SARS-CoV-2 Antibody Tests That Have Been Removed from the FDA’s Notification List
![FDA-serology-test-removed-not-for-distribution](https://covid19briefings.com/wp-content/uploads/2020/06/portion-FDA-serology-test-notification-remove-test-1024x722.jpg)
Introduction to commercially manufactured SARS-CoV-2 serology tests listed with the status of “Removed – Should Not Be Distributed.”